The Distribution of Composite SDF1/CCR5/CCR2 Genotypes in LT-NP and Progressors
| . | CCR2 . | ||
|---|---|---|---|
| Wild/wild . | Wild/mut . | Mut/mut . | |
| SDF1 wild/wild and CCR5 wild/wild | 18/393-150 | 8/6 | 0/0 |
| SDF1 wild/wild and CCR5 wild/mut | 17/2 | 2/0 | 0/0 |
| SDF1 wild/mut and CCR5 wild/wild | 12/19 | 3/6 | 2/0 |
| SDF1 wild/mut and CCR5 wild/mut | 5/7 | 1/0 | 0/0 |
| SDF1 mut/mut and CCR5 wild/wild | 1/3 | 0/1 | 0/0 |
| SDF1 mut/mut and CCR5 wild/mut | 1/0 | 0/0 | 0/0 |
| . | CCR2 . | ||
|---|---|---|---|
| Wild/wild . | Wild/mut . | Mut/mut . | |
| SDF1 wild/wild and CCR5 wild/wild | 18/393-150 | 8/6 | 0/0 |
| SDF1 wild/wild and CCR5 wild/mut | 17/2 | 2/0 | 0/0 |
| SDF1 wild/mut and CCR5 wild/wild | 12/19 | 3/6 | 2/0 |
| SDF1 wild/mut and CCR5 wild/mut | 5/7 | 1/0 | 0/0 |
| SDF1 mut/mut and CCR5 wild/wild | 1/3 | 0/1 | 0/0 |
| SDF1 mut/mut and CCR5 wild/mut | 1/0 | 0/0 | 0/0 |
Results are presented as a ratio of the number of ALT (LT-NP) subjects over IMMUNOCO (progressor) patients.